Literature DB >> 25082862

Platelets: crossroads of immunity and hemostasis.

Craig N Jenne1.   

Abstract

In this issue of Blood, Koupenova and colleagues report that platelets express functional TOLL-like receptor 7 (TLR7) and contribute to host survival during viral infection. Through a series of experiments utilizing mice deficient for TLR7 together with adoptive transfer of wild-type platelets, Koupenova et al demonstrate that platelets specifically respond to viral analogs and intact virus, leading to platelet activation and binding to various leukocyte subsets. Perhaps most importantly, this platelet activation appears absolutely essential for host survival during infection with some viral pathogens such as encephalomyocarditis virus (EMCV).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25082862     DOI: 10.1182/blood-2014-05-572875

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  Platelets in HIV: A Guardian of Host Defence or Transient Reservoir of the Virus?

Authors:  Etheresia Pretorius
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

2.  CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent.

Authors:  Kevin Kojok; Souhad El Akoum; Mira Mohsen; Walid Mourad; Yahye Merhi
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

3.  Promoting platelets is a therapeutic option to combat severe viral infection of the lung.

Authors:  Jiahuang Qiu; Juan Ma; Shuping Zhang; Jinxiang Han; Sijin Liu
Journal:  Blood Adv       Date:  2020-04-28

4.  PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.

Authors:  Elizabeth P Darga; Emily M Dolce; Fang Fang; Kelley M Kidwell; Christina L Gersch; Steven Kregel; Dafydd G Thomas; Anoop Gill; Martha E Brown; Steven Gross; Mark Connelly; Michael Holinstat; Erin F Cobain; James M Rae; Daniel F Hayes; Costanza Paoletti
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

Review 5.  Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies.

Authors:  Patrizia Ballerini; Annalisa Contursi; Annalisa Bruno; Matteo Mucci; Stefania Tacconelli; Paola Patrignani
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.